My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Nike Q2 Earnings: Revenue Beat, EPS Beat, Sha...
FedEx Stock Rallies On Better-Than-Expected Q...
Disney Hits $2 Billion Domestic Box Office, E...
Amazon Shares Rise As Company Says Operations...
4 Micron Analysts Size Up Q1 Earnings: 'An Op...
Block Positioned For Margin Expansion And EPS...
Birkenstock's High-end Lifestyle Positioning...
Astronauts Sunita Williams, Butch Wilmore's...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    REGENERON PHARMACEUTICALS INC (NASDAQ: REGN)

    Overview
    current price
    $701.85
    $701.85
    change
    -6.40 | -0.90%
    -6.40 | -0.90%
    Yesterday's Close
    708.25
    open
    710.20
    volume
    1.89 M
    30d. avg volume.
    0.86 M
    1 day
    700.83 - 717.61
    52 weeks
    693.00 - 1,211.20
    p/e
    17.36
    beta
    0.0838
    market cap
    75.85 B
    dividend yield
    0.00%
    Industry
    -
    REGN by TradingView
    News and Commentary
    Johnson & Johnson Prioritizes Sustainable Growth in M&A Amid Sector Diversification, Says Analyst Wednesday, Johnson & Johnson (...
    After UnitedHealth Cyberattack, Drug Distributor Cencora Notifies Americans' Health Information Stol... U.S. drug wholesaler Cencora Inc (
    AI Integration In Biotech & Pharma: Companies Positioned To Benefit The convergence of artificial intelligence (AI) with the biotech and pharmaceutical sectors is ushering in a new era of innovation. AI is catalyzing transformations from drug dis...
    $1 Billion Deal For Moderna To Expand Product Pipeline In China The defensive stocks sector has been underperforming most - if not all - of the remaining cyclical sectors in the U.S. economy. These preferences come from underlying dynamics in...
    FDA Pulls Authorization for GSK Antibody Drug Ineffective Against New Omicron Strain The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for GlaxoSmithKline plc's
    FDA Withdraws Authorization for Regeneron and Eli Lilly Antibody Treatments For Use The U.S. Food and Drug Administration (FDA) has withdrawn its authorization for monoclonal antibody treatments manufactured by Regeneron
    Regeneron is Working on New Antibody Therapy for Omicron, Rival Therapies Show Mixed Results Against... Following lackluster data on the effectiveness of its COVID antibody therapy against the high mutated Omicron variant, Regeneron
    October 26 Market Update Global investors on Tuesday digested new data, policy statements, and earnings reports. In Europe, the British FTSE rose 0.76%, the German DAX climbed 1.01%, the French CAC rose...
    AstraZeneca's Antibody Therapy is 77% Effective at Preventing COVID Symptoms in Late-Stage Trial AstraZeneca's (AZN&nbsp...
    Regeneron Says Antibody Cocktail Can Prevent COVID Infection Regeneron Pharmaceuticals (RE...
    StockTwits
    StockTwits
    Most Shared
    Nordstrom Q3 Sales Grow, But Analysts Remain Cautious On Stock Amid Slowing Sales And Elevated Inventory
    Warner Bros Discovery Stock Soars After Multi-Year Deal with Comcast; Comcast Shares Slide On Subscriber Loss Estimates
    Apple's iPhone 16 Stumbles On 'Intelligence' Awareness, But Pro Max Shines Bright: Analyst
    Most Popular
    Market Update: Dow, S&P 500 Climb in Best Month of 2024
    Consumer Confidence Hits 2-Year High As Recession Fears Fade: Stock Market Optimism Soars To Record High
    Nordstrom Q3 Sales Grow, But Analysts Remain Cautious On Stock Amid Slowing Sales And Elevated Inventory
    popular tags
    Earnings
    Coronavirus
    Apple
    Amazon
    Coronavirus Impact
    Covid-19
    Google
    Covid19
    Tesla
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2024 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?